FDA Approved: RASAGILINE — Original Application (Alvogen, Inc.)

View source ↗

Summary

FDA approves an original generic application for rasagiline, a monoamine oxidase-B inhibitor indicated for Parkinson's disease, from Alvogen, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

ORIG AP for RASAGILINE (RASAGILINE)